n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, May 22nd, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Sauer Energy, Inc. (SENY)

StockHideout, Investment U, DSR News, The Next Big Trade, Penny Stock Hub, BestDamnPennyStocks, Winston Small Cap, Shiznit Stocks, PennyStocks24, Fast Money Alerts, Penny Stock General, RockingPennyStocks, and Stock Shock and Awe reported earlier on Sauer Energy, Inc. (SENY), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sauer Energy, Inc. is a technology developer and manufacturer. The Company is focusing on the developing renewable energy market. It is the developer of the patented WindCharger™ brand vertical axis wind turbine (VAWT) and the manufacturer of the patented HelixWind® vertical axis wind turbine. Sauer Energy is uniting wind, solar, and storage together in harmony so that energy can be harnessed and processed to the greatest advantage. Sauer Energy has its corporate office and manufacturing facility in Oxnard, California. The Company lists on the OTCQB.

The design of Helix vertical axis wind turbine systems is purposely to be pole mounted and can respond to the demand for applications that do not require roof mounting. The Company’s technology requires few parts. As a result, it provides a new direction for wind capture, scales easily from residential to small community and up to large industrial scale.

Sauer is addressing global energy through developing complete renewables packages via three energy sources, which can help ensure the optimization of opportunities to capture the elements and produce electricity faster, simultaneously, and individually. The Company created the WindCharger™ model to provide a better solution for the use of wind capture for residential or small building use. The WindCharger™ is one of its key innovation priorities. It has a number of patents in place and more pending.

Sauer and Helix turbines underwent development to produce a quiet and low-impact technology with a high output of sustainable renewable energy. The emphasis of the WindCharger™ and Helix turbines has centered on patented disruptive technology, minimum impact on the environment, mounting flexibility, and versatility with highly efficient output.

The Company’s WindRider® turbine has a new mount and its own proprietary system for on-grid or off-grid structures. Sauer’s plan is to offer the patented helixical WindRider® model vertical axis wind turbine that uses the HelixWind technology.

The Company’s WindCutter turbine is a very powerful Darrieus design. The WindCutter has five airfoil blades that use the principle of lift to rotate the shaft and it is pole mounted. Sauer Energy’s WindCutter 2.5, VAWT design is the first model cleared for launch.
 
In November 2016, Sauer Energy announced that the WindCutter successfully completed thorough mechanical engineering review. The WindCutter, housed at ATA Engineering, Inc., was undergoing operating strain gauge testing and computer model engineering finite element analysis (FEA) simulations to ensure every part of the turbine is as safe as possible. ATA Engineering is an engineering consulting company.

This past January, Sauer Energy announced its first partnership with one of the largest alternative energy contractors in the southwest, Joe Moore, of WindSun Energy Systems (WSES), in Carlsbad, California. WindSun Energy Systems is a renewable energy enterprise. It specializes in solar and wind electric production for homes and businesses.

Sauer Energy, Inc. (SENY), closed Monday's trading session at $0.018, down 1.10%, on 114,499 volume with 14 trades. The average volume for the last 60 days is 512,593 and the stock's 52-week low/high is $0.0146/$0.05.

Interleukin Genetics, Inc. (ILIU)

Marketbeat, Wall Street Mover, TopPennyStockMovers, Streetwise Reports, Zacks, MicroCap Gems, and FeedBlitz reported on Interleukin Genetics, Inc. (ILIU), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Interleukin Genetics, Inc. develops and markets proprietary genetic tests for chronic inflammatory diseases and health-related conditions. The Company centers on the genetics of chronic inflammation. Interleukin Genetics leverage’s its research, intellectual property (IP), and genetic panel development expertise in metabolism and inflammation to facilitate the growing personalized healthcare market. Interleukin Genetics has its corporate headquarters in Waltham, Massachusetts and the Company’s shares trade on the OTCQB

Interleukin’s products encourage individuals to prevent certain chronic conditions and manage their existing health and wellness via genetic-based insights with actionable guidance. The Company operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratories Improvements Amendments (CLIA).

The Company has two main focus areas to its business. One is personalized health, centering on providing genetic information to physicians, dentists, and in some cases consumers. The second is a research and development (R&D) effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels.   

Interleukin’s lead products include its proprietary ILUSTRA™ Inflammation Management Program. This is a turnkey program that uses a simple genetic test to easily identify patients at elevated risk for developing severe periodontal disease, because of a genetic tendency to over-produce inflammation.

The Company’s lead products also include the Inherent Health® line of genetic tests - Weight Management Test; Nutritional Needs Genetic Test; Heart Health Genetic Test; and the Bone Health Genetic Test. Interleukin Genetics’ lead products additionally include its proprietary cardiovascular test to guide treatment of high risk patients.

Recently, Interleukin Genetics announced the presentation of clinical data from “The Ioannina Study” at the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC 2017) in Washington, DC, which demonstrates the ability of certain interleukin-1 (IL-1) genetic patterns together with elevated lipoprotein (a) (Lp(a)) to predict recurrent atherosclerotic cardiac events. Dr. Bechlioulis and co-workers reported the new findings from the University Hospital of Ioannina (Greece) along with collaborators from the University of California at San Diego.

This month, Interleukin Genetics announced financial results for its Q1 of 2017, ended March 31, 2017, and provided a corporate update.

Mr. Mark B. Carbeau, Interleukin Genetics’ Chief Executive Officer, said, “We continued to advance our refined strategy that focuses on the potential utility of our Interleukin-1 (IL-1) genetic platform in the development of new classes of drugs for cardiac disease, and management of patients who have suffered previous cardiac events. We believe our proprietary genetic patterns have potential to accelerate clinical development through more targeted patient recruitment and may help address important questions such as dose responses, side-effect profiles and pricing/reimbursement strategies.”

Interleukin Genetics, Inc. (ILIU), closed Monday's trading session at $0.072, up 13.21%, on 5,000 volume with 2 trades. The average volume for the last 60 days is 46,076 and the stock's 52-week low/high is $0.015/$0.083.

Protalex, Inc. (PRTX)

StreetInsider, TopStockAnalysts, Zacks, and OTCPicks reported on Protalex, Inc. (PRTX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Protalex, Inc. is a clinical-stage biopharmaceutical company based in Florham Park, New Jersey. Its emphasis is on the development of a class of drugs for treating autoimmune and inflammatory diseases. These include RA (Rheumatoid Arthritis) and ITP (Immune Thrombocytopenia). The Company’s lead product is PRTX-100, which is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria.

Rheumatoid arthritis (RA) is an autoimmune disease. RA is a disorder in which the body’s immune system mistakenly attacks the joints. Immune Thrombocytopenia (ITP) is a blood disorder. ITP can result in easy or excessive bleeding and bruising because of the body’s inability to form blood clots. Pre-clinical data indicate that PRTX-100 may have the potential to treat ITP through lessening the immune-mediated destruction of the platelets.

Protalex has open IND’s for the treatment of RA and ITP in the U.S., and in Europe, an open IMPD for ITP. The Company’s PRTX-100 can (at very low concentrations) to bind to human B-lymphocytes and macrophages and to modulate immune processes. PRTX-100 has been granted Orphan Drug Designation in the U.S. and in Europe for the treatment of ITP. Currently, it is the subject of clinical studies in the U.S. and Europe. PRTX-100 is administered as a short intravenous infusion.

The following patents were recently granted for PRTX-100:  U.S. Patent No. 9,370,552 (‘552 patent) is a continuation patent to initial U.S. patent No. 7,211,258 (Protein A compositions and methods of use) filed in 2002 and issued with method of treatment claims for RA, juvenile RA, and systemic lupus erythematosus (SLE). The ‘552 patent expands the method of treatment of PRTX-100 to include type 1 diabetes.

European Patents No. 2,570,136 and 2,206,511 (national patents in place in France, Germany, Italy, Spain, Switzerland, and the UK) includes composition claims relating to many autoimmune diseases (RA, ITP, juvenile RA, psoriasis, myasthenia gravis) and dosage expansion.
 
Canadian patents No. 2,894,098 and No. 2,481,282 consist of method of treatment claims relating to RA and SLE.  Japanese patent No. 5,523,796 claims compositions for treating psoriasis, scleroderma, Crohn’s Disease, myasthenia gravis, ulcerative colitis, psoriatic arthritis, as well as pemphigus vulgaris.

Protalex, Inc. (PRTX), closed Monday's trading session at $0.676, down 8.65%, on 200 volume with 1 trade. The average volume for the last 60 days is 177 and the stock's 52-week low/high is $0.51/$3.5001.

Viscount Mining Corp. (VLMGF)

MarketWatch, Bloomberg, and Seeking Alpha reported on Viscount Mining Corp. (VLMGF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Viscount Mining Corp. is a project generator building a portfolio of first-rate exploration properties in friendly mining jurisdictions in the U.S. The Company’s projects include Cherry Creek (Nevada – 100 percent owned) and Silver Cliff (Colorado). Cherry Creek is its flagship property. Viscount Mining is headquartered in North Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

The Company’s flagship property is centered on exploratory mining operations in the immediate vicinity of an area generally known as the Cherry Creek Project, positioned roughly 30 miles north of the town of Ely, in White Pine County, Nevada. At present, the Cherry Creek claims comprise greater than 400 unpatented and patented claims and also mill rights.

Moreover, Viscount’s Silver Cliff property is within the historic Hardscrabble Silver District. It consists of 96 lode claims where high grade silver, gold, and base metal production came from many mines during the period 1878 to 1894. The Silver Cliff property is 44 miles WSW of Pueblo, Colorado.

In late March of this year, Viscount Mining reported that in 2016, Summit Mining Exploration, Inc. continued an ongoing mineral exploration and evaluation program in the Cherry Creek mining district as part of its earn-in agreement with Viscount. Summit elected to concentrate its 2016 exploration program on a reverse‐circulation drilling program in the Flint Canyon region that it discovered in 2014‐2015 to have anomalous gold in soil and rock chips. The area has no historic mines and had only minimal modern exploration before Viscount Mining and Summit Mining Exploration.

At the beginning of this month, Viscount Mining announced the identification of promising gold and silver exploration targets on its Cherry Creek project in northwestern White Pine County, Nevada. New data collected by Summit Mining Exploration on the Cherry Creek property shows a number of areas with strong gold and silver exploration potential, which have not yet been adequately tested by concentrated geologic work or drilling.

Viscount Mining Director and Senior Geologist, Mr. Mark Abrams, said, "Summit conducted a very solid program on which we can build. The geology of the Cherry Creek district remains very permissive for finding precious and base metal deposits and we intend to advance the project forward utilizing our knowledge of the district and surrounding areas, and our extensive database."

Summit Mining Exploration completed the second full year of an evaluation program in December of 2016. It was part of fulfilling an earn-in agreement on the Cherry Creek project.

Viscount Mining Corp. (VLMGF), closed Monday's trading session at $0.22, up 3.77%, on 49,500 volume with 6 trades. The average volume for the last 60 days is 54,236 and the stock's 52-week low/high is $0.1802/$0.70.

Propanc Biopharma, Inc. (PPCH)

Money Morning, Equities.com, PennyPro, Insider Financial, Ceocast News, PennyStocks24, Greenbackers, PennyStockRumors, PricelessPennyStocks, and Top Stock Picks reported earlier on Propanc Biopharma, Inc. (PPCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A clinical stage biopharmaceutical company, Propanc Biopharma, Inc. is concentrating on developing new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian, and colorectal cancers. The Company has developed a formulation of anti-cancer compounds that exert several effects designed to control or prevent tumors from recurring and spreading throughout the body. Propanc Biopharma is based in Melbourne, Australia.

The Company’s products involve or utilize pancreatic proenzymes that are inactive precursors of enzymes. In the near term, Propanc’s intention is to target patients with limited remaining therapeutic options for the treatment of solid tumors. The Company’s future intentions include developing its lead product to treat early stage cancer and pre-cancerous diseases and also as a preventative measure for patients at risk of developing cancer based on genetic screening.

Propanc Biopharma is developing a long-term therapy founded on a pancreatic proenzyme formulation to prevent tumor recurrence and metastasis, the chief cause of patient death from cancer. Its lead product is PRP. This is a novel, patented, formulation consisting of two proenzymes mixed in a synergetic ratio that targets solid tumors. Essentially, PRP is a solution for once daily intravenous administration of a combination of the two pancreatic proenzymes - trypsinogen and chymotrypsinogen.

In late April, Propanc Biopharma announced the successful completion of the GLP-compliant, 28-day repeat-dose toxicity study for its lead product, PRP. There were no major toxicological findings after administration of PRP by intravenous injection once daily throughout the study period. PRP is a combination of the aforementioned pancreatic proenzymes in solution, for once daily intravenous administration. Propanc’s contract research partner, vivoPharm Pty Ltd, conducted the GLP-compliant study in Melbourne, Australia.

Last week, Propanc Biopharma announced that fresh new insights have arose into how cancer stem cells (CSCs) are able to resist standard treatments, become more aggressive, and spread quickly. Published in Oncogene, by researchers from the Bellvitge Biomedical Research Institute south of Barcelona, Spain, the findings have major implications for Propanc Biopharma's lead product PRP, which reprograms CSCs so that they are no longer malignant and a threat to the patient.

Propanc Biopharma, Inc. (PPCH), closed Monday's trading session at $1.40, up 0.72%, on 41,871 volume with 94 trades. The average volume for the last 60 days is 2,599 and the stock's 52-week low/high is $0.95/$1,593.75.

graphic

The QualityStocks
Company Corner

graphic
graphic

Ethema Health Corp. (GRST)

The QualityStocks Daily Newsletter would like to spotlight Ethema Health Corp. (GRST). Today, Ethema Health Corp. closed trading at $0.0449, up 28.29%, on 5,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 46,076, and its 52-week low/high is $0.015/$0.083.

Ethema Health Corp. (GRST), through its subsidiaries, offers addiction and mental health rehabilitation treatments for residents, including out-patient counseling, coaching, intervention, psychological assessment, and other related services. The company recently sold its Canadian addiction treatment operations and acquired a U.S. based treatment center in Delray Beach, Florida, a major U.S. center for drug treatment programs located between Palm Beach and Miami. The company sought to expand into the U.S., where it could revolutionize treatment in that country with the skills it acquired in Canada. The company, through a subsidiary, will own and lease their assets in Canada, offering a stable secondary cash flow. Their newly acquired U.S. treatment center will be operated through a Florida limited liability company named Seastone Delray Healthcare LLC.

More than two thirds of families have been touched by a family member's addiction to alcohol, drugs, sex, and/or gambling. The addiction treatment market in the U.S. is estimated at over $35 billion annually, with a greater need than there are facilities. In addition, the Ethema Health approach differentiates itself in a number of ways:

  • Residents are treated holistically, taking into consideration all factors that can feed addiction, rather than the isolated treatment of addiction alone. Upon admission, all residents are fully assessed by professionals of a multidisciplinary team to develop an overall holistic treatment plan. An assembled team of best-in-class experts, including psychiatrists, physicians, nurses, and clinicians, manage and support residents who have co-occurring disorders such as depression, anxiety, and trauma.
  • Support is available both before and after resident treatment. Families can receive intervention support prior to admission, an often critical time for families and patients. Follow-up treatment support is available, to ensure progress and minimize the incidence of relapse. Families and others that are integral to the recovery are encouraged to participate in counseling and education sessions for continued success after in-patient treatment.

In addition to his experience with Ethema Health, company president Shawn Leon has more than 25 years of experience managing public and private development-stage companies for various industries. He has provided financing and capital markets oversight for a number of these ventures, many of which have involved negotiations for mergers and acquisitions. Disclaimer

Ethema Health Corp. Company Blog

Ethema Health Corp. News:

Ethema Health Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida

Ethema Health Signs Definitive Agreement to Acquire Seastone of Delray, a Florida Limited Liability Company

Ethema Health Signs LOI to Acquire Aurora Recovery

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0896, up 22.07%, on 1,551 volume with 3 trades. The stock’s average daily volume over the past 60 days is 92,502, and its 52-week low/high is $0.025/$0.605.

Grey Cloak Tech, Inc. (GRCK) is a developer of industry-leading click-fraud detection software designed to overcome the most expensive and devastating threats in the digital world. Through its recently acquired subsidiary, ShareRails, Grey Cloak now also provides sophisticated e-commerce tools that help retailers evolve beyond their brick-and-mortar business practices to increase both their digital engagement and their foot traffic.

ShareRails is an online-to-offline technology firm that provides vitally important services within the trillion-dollar retail sector, helping brick-and-mortar retailers compete directly for online awareness with e-commerce-only brands. Through the ShareRails O2O platform, offline retailers can use online channels to more effectively drive sales and attract new customers.

The innovative solutions offered by ShareRails enable local retailers to capture the millions of online shopping searches they are currently missing out on because their product inventories and other key information is not currently available online and, therefore, does not appear in relevant searches and cannot be viewed digitally.

Most of today's retail sales are Web-influenced. By utilizing digital marketing channels, merchants can enhance the in-store shopping experience for customers and simultaneously boost sales. The ShareRails O2O platform enables retailers to put their product catalogs online, along with product location and availability, and make the information searchable. The platform also offers digital merchandising tools that include an outfit builder and wishlist app along with conversational shopping tools. Through ShareRails O2O, merchants can additionally tap into data that details shopper insights and behavioral trends. Add-on services include click-n-collect, reservations for in-store pickup, and local delivery.

ShareRails additionally offers Dress.li, which is a recommendation and reward platform that connects shoppers to stylists, bloggers and other fashion influencers who provide them with expert shopping advice and uniquely styled looks and, simultaneously, connects the consumers to fashion retailers. Through Dress.li, the challenge of creating a seamless social shopping experience has finally been mastered! This platform facilitates live shopping communications, curation and content creation and lets users join a global network of trendsetters. Through this network, users can inspire and be inspired, accessing and sharing product recommendations and unique looks and receiving rewards each time another user makes a purchase from their recommendations. This platform not only provides an enjoyable and exciting network for shoppers and fashionistas, but it simultaneously supplies retailers with a lucrative outlet for acquiring new customers through a built-in global sales force of fashion influencers. As these Dress.li stylists create and share looks, they also deliver pre-qualified sales leads and conversions and are rewarded for doing so.

Joined together, Grey Cloak Tech's industry-leading click-fraud detection solutions and the exciting retail-boosting products delivered through ShareRails offer a broad package of services to both protect businesses in the digital world and help them utilize digital channels to bolster their sales and enhance customer engagement.

Grey Cloak Tech continues to serve as an industry leader in developing the most effective and comprehensive weapons to fight online security threats. The company is keenly focused on protecting its clients' interests through the identification of fraud patterns at the very earliest stages. When businesses partner with Grey Cloak Tech, they can look forward to benefiting from industry-leading technology, a top-tier client services team, and an augmented bottom line. Disclaimer

Grey Cloak Tech, Inc. Company Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Tech's ShareRails Launches first Searchable Mall for Pacific Retail Capital Partners, Allowing Consumers to Find Online and Buy In Store

Grey Cloak Tech Completes the Acquisition of ShareRails O2O E-commerce Services Platform

Grey Cloak Tech, Inc. (GRCK) is “One to Watch”

Kootenay Zinc Corp. (CSE:ZNK) (OTCQB:KTNNF)

The QualityStocks Daily Newsletter would like to spotlight Kootenay Zinc Corp. (KTNNF). Today, Kootenay Zinc Corp. closed trading at $0.137, up 14.93%, on 79,943 volume with 20 trades. The stock’s average daily volume over the past 60 days is 96,156, and its 52-week low/high is $0.1186/$0.59.

Kootenay Zinc Corp. (KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine.

Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well into the year 2020, putting increased pressure on zinc supply.

For 2017, Goldman Sachs has predicted a 360,000 ton shortage of zinc, along with a subsequent rise in zinc prices to $2,500 per metric ton in the first half of the year. Zinc continues to make history in the metals exchange, driving significant interest in the market amid supply constraints in concentrates and refined metal drive prices.

Ready to claim its share of the market, Kootenay Zinc is focused on its Sully Property. It comprises 1,375 hectares and overlies rocks of similar age and origin as those which host the legendary Sullivan deposit. The Sullivan mine was discovered in 1892, and is known to be one of the world's largest SEDEX deposits. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately 300 million ounces of silver, 8 million tonnes of zinc and 8 million tonnes of lead.

Notably, geophysical data suggests that Kootenay Zinc's Sully project and Sullivan share many geological features:

  • Strata at Sully are in the same sedimentary basin as the Sullivan mine
  • The exact stratigraphic time horizon at which Sullivan formed is present at Sully
  • Filtered AeroMag anomalies coincident with Sullivan Time at Sully appear similar to Sullivan
  • Gravity anomaly at Sully indicates excess mass of comparable magnitude to Sullivan
  • Pb-Zn is present as traces in outcrop, drill core and in a soil geochemical anomaly

The squeeze in zinc supplies particularly affects China, which is both the world's largest zinc consumer and its largest producer, with 4.9 million tons of output in 2015. Chinese manufacturers are now being forced to import zinc for use in cars, household appliances, paints, rubber products and smartphones.

Zinc's rally shows no sign of slowing down in the near future, and companies that currently occupy stake in a zinc deposit find themselves in an enviable position over miners rushing to find new reserves. With its Sully Project, Kootenay Zinc could be on track to capture its share of the market, guided by a management team of mining directors and executives that currently lead some of the world's best mining companies and have been involved in world-class discoveries which sold for billions of dollars. The company's technical team includes industry experts that have worked on mega-mining projects, including the Sullivan and Voisey Bay projects. Disclaimer

Kootenay Zinc Corp. Company Blog

Kootenay Zinc Corp. News:

NetworkNewsWire Announces Publication on the Bullish Outlook for Zinc and the Companies Set to Profit

Kootenay Zinc Corp.: Sully Project Exploration Update

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) is “One to Watch”

ProBility Media Corp. (PBYA)

The QualityStocks Daily Newsletter would like to spotlight ProBility Media Corp. (PBYA). Today, ProBility Media Corp. closed trading at $0.416, off by 0.24%, on 940 volume with 2 trades. The stock’s average daily volume over the past 60 days is 3,860, and its 52-week low/high is $0.1205/$1.16.

ProBility Media Corp. (PBYA) based in Houston, TX, is an EdTech Company that is building the first full service training and career advancement brand for the skilled trades. Through both acquisitions and organic growth, ProBility is executing a disruptive strategy of defragmenting the market place of disparate companies servicing fifteen vertical categories in over sixty skilled trades. ProBility has positioned itself as a key industrial training resource for individuals, small- and medium-size businesses as well as enterprise customers offering consistent high-quality training services and materials for education, testing, and career advancement.

Through its Electrical Training Division, the company has become the biggest wholesaler of electrical codes and test preparation materials in the U.S., while its Construction Training Division is one of the largest certification providers in the country, with programs in 22 states, and continuing to grow. The company serves corporate accounts and government buyers, and also offers advisory services for companies of all sizes.

Companies currently under the ProBility Media conglomerate include:

  • Brown Technical Media Corp. – An online web business with multiple micro web sites featuring training materials and codes and standards sought by engineers, construction workers, scientists and other tradesmen in a wide variety of fields.
  • Brown Technical Publications – A proprietary publishing business generating copyrighted training materials for engineers, construction workers, scientists and other tradesman in a wide variety of fields.
  • 1ExamPrep – E-Learning, education and exam preparation for contractors via the cheapest, fastest and most effective exam prep school in the industry instituting our 4-point proven learning system.
  • National Electrical Wholesale Providers – In the business of distributing wholesale industrial, commercial and residential training materials including HVAC, plumbing and electrical.

ProBility's technology platform features virtual reality training for the crane business to be expanded into other industries, online subscription services for enterprise level companies, and recurring revenue streams. In addition, the company is already beginning to explore international expansion options, supported by the fact that other countries have adopted U.S. based codes, and have used U.S. training services.

The company's acquisition strategy targets operations that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, QC firms, and additional vocational industries. Disclaimer

ProBility Media Corp. Company Blog

ProBility Media Corp. News:

ProBility Media Corp. Expands Distribution with New 2017 Electrician Exam Preparation Series

ProBility Media Corp. Appoints Billy Smith to the Newly Created Vocational Advisory Board

ProBility Media Corp. Files 10Q, Reports Third Consecutive Quarter of Revenue Growth

Stealth Technologies Inc. (STTH)

The QualityStocks Daily Newsletter would like to spotlight Stealth Technologies Inc. (STTH). Today, Stealth Technologies Inc. closed trading at $0.015, even for the day. The stock’s average daily volume over the past 60 days is 32,337, and its 52-week low/high is $0.01/$0.05.

Founded in 1999, Stealth Technologies Inc. (STTH) is focused on developing and marketing products that deliver cost effective, independently validated solutions for large addressable international and domestic markets. The company's primary target is identity protection and personal safety.

The Stealth Card represents the company's flagship solution for identity protection. Today there are more than 1.5 billion credit and debit cards in circulation with RFID chips, making it easier than ever for identity thieves to steal sensitive information without contact. The paper-thin Stealth Card offered by Stealth Technologies protects up to 12 RFID credit cards in a wallet without any batteries or charging requirements.

StealthIdentityTheft.com is an expansion of the company's commitment to provide first-rate identity protection solutions. The proprietary system underlying this identity protection and recovery service was designed in partnership with law enforcement officials. Utilizing the most effective methods of prevention involving a two-step process, StealthIdentityTheft.com is a superior answer to the non-stop identity theft taking place every day.

The international marketplace was infiltrated by Stealth Technologies when the company launched its 911 HELP NOW™ emergency medical alert device. Providing direct access with 911 service at a touch of a button, the device is packed with powerful features including a full year of battery life from standard AAA batteries, compact ergonomic design, 2-way voice and a durable, splash resistant design.

Stealth Mobile is the latest product offering introduced to leverage the Stealth Technologies' brand and sales channels established by the other products. Similar to the Stealth Card, Stealth Mobile prevents electronic pickpocketing. The product guards NFC transmissions emitted by cell phone devices, which can include personal information, messages and financial data.

Stealth Technologies recognizes the value of the rapid sales growth generated by these technologies and has multiple patents pending to safeguard its investments. With an expanding product suite and ongoing expansion into the identity theft protection marketplace, Stealth Technologies remains committed to its focus on increased growth and profitability. Disclaimer

Stealth Technologies Inc. Company Blog

Stealth Technologies Inc. News:

Stealth Technologies Announces 5 New Products

Stealth Technologies Highlights Opportunities from Attendance at Leading Real Estate, Home Staging Conference

NetworkNewsWire Releases Exclusive Audio Interview with Stealth Technologies, Inc. (STTH)

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMarketWatch
(OPXAW) +57.50%

2.

Trader Power News
(NUTR) +50.54%

3.

CFN Media Group
(KWFLF) +40.35%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251